Ginkgo Bioworks Hldgs Inc (DNA)
9.4400  -0.8900 (-8.62%)

Ginkgo Bioworks is a biotechnology company that focuses on the design and engineering of microbial strains for various applications across diverse industries, including pharmaceuticals, agriculture, and industrial biotechnology. By leveraging advanced genetic engineering and synthetic biology techniques, Ginkgo aims to create custom organisms that can produce valuable ingredients, enhance agricultural yields, or contribute to sustainable manufacturing processes. The company operates through a platform model, allowing collaborations with partners to transform biological systems into efficient and scalable solutions that address real-world challenges, all while paving the way for a future with more sustainable and tailored biological products.

SummaryNewsPress ReleasesChartHistorical
Previous Close10.33
Open10.28
Bid9.310
Ask9.530
Day's Range9.260 - 10.48
52 Week Range5.260 - 75.20
Volume1,500,700
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume1,535,739

News & Press Releases

Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · September 17, 2024
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?fool.com
Could this beaten-down stock turn things around in the near future?
Via The Motley Fool · September 5, 2024
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stockfool.com
The risks may resolve in a year or so but seizing the opportunities will take longer.
Via The Motley Fool · September 3, 2024
This 1 AI Stock Could Revolutionize Biotech and Pharmafool.com
The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.
Via The Motley Fool · September 2, 2024
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?fool.com
Its ambitious business model may not be sustainable.
Via The Motley Fool · August 24, 2024
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Insights into Ginkgo Bioworks Holdings's Upcoming Earningsbenzinga.com
Via Benzinga · November 11, 2024
What's Going On With Ginkgo Bioworks Stock This Week?benzinga.com
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on.
Via Benzinga · September 18, 2024
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Todayfool.com
The company is forging ahead with next-generation drug development solutions.
Via The Motley Fool · September 17, 2024
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Developmentbenzinga.com
Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by leveraging AI and proprietary biological data, offering affordable and accessible tools for researchers.
Via Benzinga · September 17, 2024
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Whybenzinga.com
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud.
Via Benzinga · September 17, 2024
From Promise to Peril: The Downfall of Ginkgo Bioworksbenzinga.com
Via Benzinga · August 26, 2024
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?fool.com
Have shares of the troubled life sciences business fallen too far?
Via The Motley Fool · August 15, 2024
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocksfool.com
Efficiency in core processes is set to increase substantially due to AI.
Via The Motley Fool · August 13, 2024
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024investorplace.com
DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Splitinvestorplace.com
Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month.
Via InvestorPlace · August 2, 2024
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money?investorplace.com
Which of these 7 meme stocks are likely to punish investors and which are likely to provide free money? Read on to see.
Via InvestorPlace · July 23, 2024
7 Sorry Biotech Stocks Set to Make Investors Sadinvestorplace.com
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via InvestorPlace · July 22, 2024
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buyinvestorplace.com
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up. 
Via InvestorPlace · July 18, 2024
DNA Stock: Ginkgo Bioworks Announces New Collaborationinvestorplace.com
Although Ginkgo Bioworks’ partnership with an agricultural innovator boosted DNA stock, the company still faces challenges.
Via InvestorPlace · July 16, 2024
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?fool.com
A recovery plan is underway, but it isn't a slam dunk.
Via The Motley Fool · July 14, 2024
3 Stocks to Avoid Like the Plague in 2024investorplace.com
Avoid these three stocks like the plague in 2024 to protect your portfolio from potential pitfalls and losses.
Via InvestorPlace · July 11, 2024
3 High-Risk, Sky-High Reward Stocks to Buy for Under $1investorplace.com
These high-risk penny stocks may be cheap, but their low per-share pricing conceals unique tailwinds that could propel them higher.
Via InvestorPlace · July 10, 2024
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Heartedinvestorplace.com
Ginkgo Bioworks stock is down, but this doesn't mean it's a bargain as Ginkgo Bioworks faces a serious delisting threat.
Via InvestorPlace · July 10, 2024
7 F-Rated Stocks To Sell in Julyinvestorplace.com
If you're going to outperform even a basic index fund this year, you need to identify any F-rated stocks to sell in July.
Via InvestorPlace · July 8, 2024